Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015 - PubMed (original) (raw)
. 2018 Nov;41(11):2306-2315.
doi: 10.2337/dc18-0831. Epub 2018 Aug 21.
Affiliations
- PMID: 30131397
- PMCID: PMC7849201
- DOI: 10.2337/dc18-0831
Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015
Yiling J Cheng et al. Diabetes Care. 2018 Nov.
Abstract
Objective: Cardiovascular disease (CVD) mortality has declined substantially in the U.S. The aims of this study were to examine trends and demographic disparities in mortality due to CVD and CVD subtypes among adults with and without self-reported diabetes.
Research design and methods: We used the National Health Interview Survey (NHIS) (1985-2014) with mortality follow-up data through the end of 2015 to estimate nationally representative trends and disparities in major CVD, ischemic heart disease (IHD), stroke, heart failure, and arrhythmia mortality among adults ≥20 years of age by diabetes status.
Results: Over a mean follow-up period of 11.8 years from 1988 to 2015 of 677,051 adults, there were significant decreases in major CVD death (all P values <0.05) in adults with and without diabetes except adults 20-54 years of age. Among adults with diabetes, 10-year relative changes in mortality were significant for major CVD (-32.7% [95% CI -37.2, -27.9]), IHD (-40.3% [-44.7, -35.6]), and stroke (-29.2% [-40.0, -16.5]), but not heart failure (-0.5% [-20.7, 24.7]), and arrhythmia (-12.0% [-29.4, 77.5]); the absolute decrease of major CVD among adults with diabetes was higher than among adults without diabetes (P < 0.001). Men with diabetes had larger decreases in CVD death than women with diabetes (P < 0.001).
Conclusions: Major CVD mortality in adults with diabetes has declined, especially in men. Large reductions were observed for IHD and stroke mortality, although heart failure and arrhythmia deaths did not change. All race and education groups benefitted to a similar degree, but significant gaps remained across groups.
© 2018 by the American Diabetes Association.
Conflict of interest statement
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
Figures
Figure 1—
Trends in mortality by age-groups and select CVDs among adults with diabetes. Among U.S. adults both with and without diabetes by three age-groups (20–54, 55–65, and ≥65 years of age), the sex- and race/ethnicity-adjusted death rates from major CVD including IHD and stroke have decreased steadily from 1988 to 2015, especially among adults ≥65 years of age with diabetes. The solid lines represent the mortality of adults with diabetes, and the dashed lines represent the mortality of adults without diabetes. The green lines represent the mortality of adults 20–54 years of age, the orange lines represent the mortality of adults 55–65 years of age, and the blue lines represent the mortality of adults ≥65 years of age.
Comment in
- Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015. Diabetes Care 2018;41:2306-2315.
Manicardi V, Vicentini M, Ballotari P, Venturelli F, Giorgi Rossi P. Manicardi V, et al. Diabetes Care. 2019 Apr;42(4):e62. doi: 10.2337/dc18-2175. Diabetes Care. 2019. PMID: 30894386 No abstract available. - Response to Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015. Diabetes Care 2018;41:2306-2315.
Cheng YJ, Imperatore G, Albright AL, Gregg EW. Cheng YJ, et al. Diabetes Care. 2019 Apr;42(4):e63. doi: 10.2337/dci18-0057. Diabetes Care. 2019. PMID: 30894387 Free PMC article. No abstract available.
Similar articles
- Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey.
Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L. Gregg EW, et al. Diabetes Care. 2012 Jun;35(6):1252-7. doi: 10.2337/dc11-1162. Diabetes Care. 2012. PMID: 22619288 Free PMC article. - Educational disparities in mortality among adults with diabetes in the U.S.
Dray-Spira R, Gary-Webb TL, Brancati FL. Dray-Spira R, et al. Diabetes Care. 2010 Jun;33(6):1200-5. doi: 10.2337/dc09-2094. Epub 2010 Mar 3. Diabetes Care. 2010. PMID: 20200302 Free PMC article. - Diabetes and the risk of infection-related mortality in the U.S.
Bertoni AG, Saydah S, Brancati FL. Bertoni AG, et al. Diabetes Care. 2001 Jun;24(6):1044-9. doi: 10.2337/diacare.24.6.1044. Diabetes Care. 2001. PMID: 11375368 - Trends in the epidemiology of cardiovascular disease in the UK.
Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N. Bhatnagar P, et al. Heart. 2016 Dec 15;102(24):1945-1952. doi: 10.1136/heartjnl-2016-309573. Epub 2016 Aug 22. Heart. 2016. PMID: 27550425 Free PMC article. Review. - Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis.
Lee C, Joseph L, Colosimo A, Dasgupta K. Lee C, et al. Diabetes Metab. 2012 Nov;38(5):420-7. doi: 10.1016/j.diabet.2012.04.002. Epub 2012 Jun 7. Diabetes Metab. 2012. PMID: 22682738 Review.
Cited by
- Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model.
Gülcan MB, Demirtaş H, Özer A, Yığman Z, Dursun AD, Arslan M, Oktar GL. Gülcan MB, et al. Drug Des Devel Ther. 2024 Sep 20;18:4203-4213. doi: 10.2147/DDDT.S482309. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39319194 Free PMC article. - Dietary Modulations in Preventing Cardiometabolic Risk in Individuals with Type 2 Diabetes.
Dal N, Bilici S. Dal N, et al. Curr Nutr Rep. 2024 Sep;13(3):412-421. doi: 10.1007/s13668-024-00541-z. Epub 2024 May 20. Curr Nutr Rep. 2024. PMID: 38767826 Free PMC article. Review. - Comparison of intramyocellular lipid metabolism in patients with diabetes and male athletes.
Mezincescu AM, Rudd A, Cheyne L, Horgan G, Philip S, Cameron D, van Loon L, Whitfield P, Gribbin R, Hu MK, Delibegovic M, Fielding B, Lobley G, Thies F, Newby DE, Gray S, Henning A, Dawson D. Mezincescu AM, et al. Nat Commun. 2024 May 15;15(1):3690. doi: 10.1038/s41467-024-47843-y. Nat Commun. 2024. PMID: 38750012 Free PMC article. Clinical Trial. - Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease.
Limonte CP, Lamprea-Montealegre JA, Tuttle KR. Limonte CP, et al. Semin Nephrol. 2024 Mar;44(2):151520. doi: 10.1016/j.semnephrol.2024.151520. Epub 2024 May 5. Semin Nephrol. 2024. PMID: 38705774 Review. - Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala S, Rajan J, Yang E, DeFronzo RA. Neppala S, et al. Curr Cardiol Rep. 2024 Jun;26(6):623-633. doi: 10.1007/s11886-024-02055-0. Epub 2024 Apr 18. Curr Cardiol Rep. 2024. PMID: 38634964 Review.
References
- Sarwar N, Gao P, Seshasai SR, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [published correction appears in Lancet 2010;376:958]. Lancet 2010; 375:2215–2222 - PMC - PubMed
- Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017;376:1407–1418 - PubMed
- Harding JL, Shaw JE, Peeters A, Davidson S, Magliano DJ. Age-specific trends from 2000-2011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people. Diabetes Care 2016;39:1018–1026 - PubMed
- Gregg EW, Cheng YJ, Srinivasan M, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 2018;391:2430–2440 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical